Igor Torgov (1912 - 2007)
|
Very recently, Benjamin List’s
laboratory at the Max Planck Institute disclosed a report describing a
catalytic asymmetric version of the Torgov cyclization (see above, conversion
of 1 à
‘Torgov’s diene’). Mechanistically, the Torgov cyclization involves (1)
isomerization of intermediate 1 to the endocyclic D8,9 isomer A (2) Prins-type cation-olefin
cyclization (3) deprotonation of the ensuing carbocation to give the alcohols B
and, finally, (4) isomerization and dehydration of B, which furnishes the
intact Torgov diene. List and co-workers recognized that the chirogenic,
stereo-determining step is likely the cyclization of intermediate A and that
this transformation might be catalyzed by an enantiopure Brønsted
acid. Upon screening of a range of acids, a novel chiral disulfonimide (DSI)
(shown above, see box) emerged that was uniquely able to deliver the requisite diene
at low temperature and with high enantioselectivity. A gram-scale Torgov
cyclization of intermediate 1, catalyzed by the unique pentafluorothio- and
nitro-containing DSI, proceeded in high yield to furnish Torgov’s diene with an
enantiomeric ratio of 96.5:3.5. A single recrystallization provided essentially
optically pure material (>99.9:0.1 e.r.). Moreover, the precious DSI could
be recovered from the reaction in 88% yield. List’s group then repeated a
two-step procedure that was previously developed by E. J. Corey’s laboratory to
diastereoselectively reduce Torgov’s diene to estrone methyl ether (3). Methyl
ether deprotection yielded fully synthetic (+)-estrone,
thus completing the shortest route to the bioactive steroid reported to date.
List’s achievement in the
enantioselective chemical synthesis of estrone is rivaled in its conciseness
only by the work of E. J. Corey’s group, which has previously disclosed no less than three (!!!) distinct enantioselective
processes. The first, reported in 2004 (chemistry not shown), uses a catalytic
enantioselective Diels-Alder reaction as the key step. The second, outlined in
the scheme above, proceeds through the intermediacy of Torgov’s diene. In this
work, the achiral diketone 1 is first reduced enantioselectively using
oxazaborolidine catalysis in combination with the reductant catecholborane. A
single recrystallization of the product from ethyl acetate-hexane affords
highly enantioenriched 4 (99% ee). Torgov cyclization of mono-ketone 4 then
proceeds efficiently in methanolic hydrochloric acid and the ensuing optically
active dienol 5 is oxidized to Torgov’s diene by the IBX reagent. Finally, the
same two-step reductive sequence from above, borrowed by List and co-workers, efficiently
converts Torgov’s diene into estrone methyl ether. An alternate enantioselective
total synthesis of Torgov’s diene, reported by Corey’s group in 2008, is
discussed here. We should note that, these days, (+)-estrone
is commercially available from Sigma-Aldrich for about $1.75/gram.
Chiral synthesis (enantioselective synthesis, also called asymmetric synthesis) is the synthesis of a compound by a method that favors the formation of a specific enantiomer or diastereomer. It is a key process in modern chemistry and is particularly important in the field of medicinal chemistry, Chiral Synthesis
ReplyDelete